Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Adjunctive Bright Light Therapy for Opioid Use Disorder

NCT: NCT05459922 · COMPLETED

NCT IDNCT05459922
StatusCOMPLETED
Start Date2022-10-23
Completion2026-02-11

Brief Summary

Investigators propose to conduct a pilot single-blind, parallel arm, randomized placebo-controlled trial evaluating the feasibility, acceptability, and preliminary efficacy of bright light therapy on reward system functioning among patients undergoing medication-assisted treatment for opioid use disorder.

Frequently Asked Questions

What is Adjunctive Bright Light Therapy for Opioid Use Disorder?

Adjunctive Bright Light Therapy for Opioid Use Disorder is a clinical trial registered under NCT05459922. Current status: COMPLETED.

What is the status of NCT05459922?

The current status of NCT05459922 (Adjunctive Bright Light Therapy for Opioid Use Disorder) is: COMPLETED.

When did Adjunctive Bright Light Therapy for Opioid Use Disorder start?

Adjunctive Bright Light Therapy for Opioid Use Disorder started on 2022-10-23.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.